Financhill
Back

REX American Resources Corp. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison

Sell
44

REX
REX American Resources Corp.

Last Price:
$34.25
Seasonality Move:
7.7%
Buy
57

LYEL
Lyell Immunopharma, Inc.

Last Price:
$35.06
Seasonality Move:
-22.7%
Sell
44
REX American Resources Corp. (REX) is a Sell

Is REX American Resources Corp. a Buy, Sell or Hold?

  • The current REX American Resources Corp. [REX] share price is $34.18. The Score for REX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • REX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Lyell Immunopharma, Inc. (LYEL) is a Buy

Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?

  • The current Lyell Immunopharma, Inc. [LYEL] share price is $35.09. The Score for LYEL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • LYEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

REX Stock Price Chart

What is REX American Resources Corp.'s stock price today?

  • The REX American Resources Corp. share price today is $34.18
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REX is experiencing buying pressure, which is a positive indicator for future bullish movement.

LYEL Stock Price Chart

What is Lyell Immunopharma, Inc.'s stock price today?

  • The Lyell Immunopharma, Inc. share price today is $35.09
    The current trend is moderately bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.

REX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.33 Buy
Relative Strength Index (14 RSI): 57.53 Buy
Chaikin Money Flow: 104183 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.56 - 34.18) Buy
Bollinger Bands (100): (29.48 - 33.38) Buy

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.23 Buy
Relative Strength Index (14 RSI): 66.16 Buy
Chaikin Money Flow: -92149 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.48 - 34.66) Buy
Bollinger Bands (100): (10.81 - 25.25) Buy

REX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34 Buy
20-day SMA: 33.64 Buy
50-day SMA: 32.78 Buy
200-day SMA: 26.79 Buy
8-day EMA: 28.28 Buy
20-day EMA: 17.2 Buy
50-day EMA: 8.34 Buy
200-day EMA: 2.31 Buy

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.85 Buy
20-day SMA: 30.4 Buy
50-day SMA: 22.87 Buy
200-day SMA: 13.87 Buy
8-day EMA: 35.03 Buy
20-day EMA: 31.05 Buy
50-day EMA: 24.98 Buy
200-day EMA: 18 Buy

REX American Resources Corp. Earnings Growth & REX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.04 per share.

Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.

REX American Resources Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyell Immunopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):